923926-28-7Relevant articles and documents
Dipeptide-based highly potent doxorubicin antibody conjugates
Jeffrey, Scott C.,Nguyen, Minh T.,Andreyka, Jamie B.,Meyer, Damon L.,Doronina, Svetlana O.,Senter, Peter D.
, p. 358 - 362 (2007/10/03)
Highly potent and novel derivatives of doxorubicin were linked to monoclonal antibodies (mAbs) for site-specific drug delivery. Drug linker 5 consisted of a dipeptide linker attached directly to the daunosamine nitrogen of the n-butyldiacetate doxorubicin